Evaluación de Tecnologías Sanitarias

Outcomes and costs associated with PHiD-CV, a new protein D conjugate pneumococcal vaccine, in four countries

Talbird SE, Taylor TN, Knoll S, Frostad CR, Garcia Marti S. Outcomes and costs associated with PHiD-CV, a new protein D conjugate pneumococcal vaccine, in four countries. Vaccine. 2010;28 Suppl 6:G23-29.

Outcomes and costs associated with PHiD-CV, a new protein D conjugate pneumococcal vaccine, in four countries Ver más »

Estimation of the burden of cardiovascular disease attributable to modifiable risk factors and cost-effectiveness analysis of preventative interventions to reduce this burden in Argentina

Rubinstein A, Colantonio L, Bardach A, et al. Estimation of the burden of cardiovascular disease attributable to modifiable risk factors and cost-effectiveness analysis of preventative interventions to reduce this burden in Argentina. BMC Public Health. 2010;10:627.

Estimation of the burden of cardiovascular disease attributable to modifiable risk factors and cost-effectiveness analysis of preventative interventions to reduce this burden in Argentina Ver más »

Economic evaluation guidelines in Latin America: a current snapshot

Augustovski F, Garay OU, Pichon-Riviere A, Rubinstein A, Caporale JE. Economic evaluation guidelines in Latin America: a current snapshot. Expert Rev Pharmacoecon Outcomes Res. 2010;10(5):525-537.

Economic evaluation guidelines in Latin America: a current snapshot Ver más »

Health technology assessment for resource allocation decisions: are key principles relevant for Latin America?

Pichon-Riviere A, Augustovski F, Rubinstein A, Marti SG, Sullivan SD, Drummond MF. Health technology assessment for resource allocation decisions: are key principles relevant for Latin America? Int J Technol Assess Health Care. 2010;26(4):421-427.

Health technology assessment for resource allocation decisions: are key principles relevant for Latin America? Ver más »

Economic evaluations on cardiovascular preventive interventions in Argentina

Colantonio LD, Marti SG, Rubinstein AL. Economic evaluations on cardiovascular preventive interventions in Argentina. Expert Rev Pharmacoecon Outcomes Res. 2010;10(4):465-473.

Economic evaluations on cardiovascular preventive interventions in Argentina Ver más »

Health-worker barriers to syphilis screening in pregnant women in Bolivia’s Los Andes network

F. Tinajeros,L. R. Ares,V. Elías,L. Reveiz,F. Sánchez,M. Mejía,R. Hernández and R. Revollo. [Health-worker barriers to syphilis screening in pregnant women in Bolivia’s Los Andes network]. Rev Panam Salud Publica. 2017;41:10.26633/rpsp.2017.21.

Health-worker barriers to syphilis screening in pregnant women in Bolivia’s Los Andes network Ver más »

Estimate of the cardiovascular disease burden attributable to modifiable risk factors in Argentina

Rubinstein A, Colantonio L, Bardach A, et al. [Estimate of the cardiovascular disease burden attributable to modifiable risk factors in Argentina]. Rev Panam Salud Publica. 2010;27(4):237-245.

Estimate of the cardiovascular disease burden attributable to modifiable risk factors in Argentina Ver más »

Influence of trial registration on reporting quality of randomized trials: study from highest ranked journals

Reveiz L, Cortes-Jofre M, Asenjo Lobos C, et al. Influence of trial registration on reporting quality of randomized trials: study from highest ranked journals. J Clin Epidemiol. 2010;63(11):1216-1222.

Influence of trial registration on reporting quality of randomized trials: study from highest ranked journals Ver más »